The Journal of Allergy and Clinical Immunology
Volume 120, Issue 6 , Pages 1418-1424, December 2007

B cell–derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines

  • Charlotte Admyre, PhD

      Affiliations

    • Department of Medicine, Clinical Allergy Research Unit, Karolinska Institutet, Stockholm, Sweden
    • Corresponding Author InformationReprint requests: Charlotte Admyre, PhD, Karolinska Institutet, Department of Medicine, Clinical Allergy Research Unit, Karolinska University Hospital L2:04, 171 76 Stockholm, Sweden.
  • ,
  • Barbara Bohle, PhD

      Affiliations

    • Department of Pathophysiology, Division of Immunopathology, Center for Physiology and Pathophysiology and Christian Doppler Laboratory for Allergy Research, Medical University of Vienna, Vienna, Austria
  • ,
  • Sara M. Johansson, MSc

      Affiliations

    • Department of Medicine, Clinical Allergy Research Unit, Karolinska Institutet, Stockholm, Sweden
  • ,
  • Margarete Focke-Tejkl, PhD

      Affiliations

    • Department of Pathophysiology, Division of Immunopathology, Center for Physiology and Pathophysiology and Christian Doppler Laboratory for Allergy Research, Medical University of Vienna, Vienna, Austria
  • ,
  • Rudolf Valenta, MD

      Affiliations

    • Department of Pathophysiology, Division of Immunopathology, Center for Physiology and Pathophysiology and Christian Doppler Laboratory for Allergy Research, Medical University of Vienna, Vienna, Austria
  • ,
  • Annika Scheynius, MD, PhD

      Affiliations

    • Department of Medicine, Clinical Allergy Research Unit, Karolinska Institutet, Stockholm, Sweden
  • ,
  • Susanne Gabrielsson, PhD

      Affiliations

    • Department of Medicine, Clinical Allergy Research Unit, Karolinska Institutet, Stockholm, Sweden

Received 12 February 2007; received in revised form 30 May 2007; accepted 26 June 2007. published online 17 September 2007.

Background

Exosomes are vesicles of 30 to 100 nm produced by inward budding of endosomal compartments and are released by a range of different cell types. Exosomes from antigen-presenting cells carry immunorelevant molecules like MHC class I and II and costimulatory molecules and thus are suggested to have a role in immune modulation.

Objective

To investigate the role of antigen-presenting cell derived exosomes in allergen presentation and T-cell stimulation.

Methods

Exosomes were isolated from supernatants of B-cell lines derived from patients with birch pollen allergy. The exosomes were characterized with regard to the expression of surface molecules by flow cytometry. Moreover, exosomes were loaded with T-cell–activating peptides from the major birch allergen Bet v 1, and binding was tested with ELISA. Loaded exosomes were used for stimulation of Bet v 1–specific T-cell lines. Cell proliferation and cytokine production were assessed.

Results

The exosomes had a phenotype typical of B cell–derived exosomes with expression of MHC, costimulatory molecules like CD86, tetraspanin proteins such as CD81, and CD19. Furthermore, B cell–derived exosomes bound Bet v 1–derived peptides and subsequently induced a dose-dependent T-cell proliferation. In addition to proliferation, T cells synthesized the cytokines IL-5 and IL-13 in response to peptide-loaded exosomes.

Conclusion

These results demonstrate for the first time that exosomes isolated from B cells can present allergen-derived peptides and thereby induce T-cell proliferation and TH2-like cytokine production.

Clinical implications

Our data suggest that exosomes from B lymphocytes are an immunostimulatory factor in allergic immune responses.

Key words: Exosomes, Bet v 1, allergy, T cells, B cells

Abbreviations used: APC, Antigen-presenting cell, BAL, Bronchoalveolar lavage, CBA, Cytometric bead array, cpm, Counts per minute, DC, Dendritic cell, FITC, Fluorescein isothiocyanate, PE, Phycoerythrin, TCL, T-cell line

 

 Supported by the Swedish Research Council (grants 15243-01, 1524-03-2, 15193-01A and 7924-18A), the Cancer and Allergy Foundation, the Center for Allergy Research Karolinska Institutet, the European Academy of Allergology and Clinical Immunology major award, the Eric and Edith Fernström Foundation for Medical Research, the Hesselman Foundation, the Magnus Bergvall Foundation, the Swedish Asthma and Allergy Association's Research Foundation, the Swedish Society of Medicine, the Åke Wiberg Foundation, the Austrian Science Fund (grants F1807 and F1815), and the Christian Doppler Research Association.

 Disclosure of potential conflict of interest: R. Valenta has consulting arrangements with Phadia and Biomay. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(07)01262-6

doi:10.1016/j.jaci.2007.06.040

The Journal of Allergy and Clinical Immunology
Volume 120, Issue 6 , Pages 1418-1424, December 2007